Ingrid Engebretsen

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)Respiratory diseasesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 02, 2025
Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-20.

Ingrid Engebretsen, Francisco Oteiza, Elisabeth Floberghagen Birkelund

|Dec 12, 2024
Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) - a register-based study.

Christoffer Bugge, Ingrid Engebretsen, Ivar Sønbø Kristiansen

|Nov 19, 2024
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy.

Ingrid Engebretsen, Kristina Malene Ødegaard, Sigrun Halvorsen

|Aug 22, 2024
Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register study.

Anne M Kerola, Eirik Ikdahl, Ingrid Engebretsen

|Feb 07, 2024
The epidemiology and societal costs of myasthenia gravis in Norway: A non-interventional study using national registry data.

Ingrid Engebretsen, Nils Erik Gilhus, Ivar Sønbø Kristiansen

|Nov 28, 2022
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs.

Ingrid Engebretsen, John Munkhaugen, Christoffer Bugge

Pageof 1